Dignity Health i Arizona o loʻo faʻalauiloaina le suʻesuʻega muamua suʻesuʻe i Amerika i Matu lea e faʻaogaina ai suʻega faʻatagata e iloa ai alii ma tamaitai e ono aʻafia i maʻi fatu e faʻavae i luga o le fausaga o latou DNA. Afai e fa'amaonia lelei i su'ega fa'afoma'i, e mafai ona fa'aaogaina lenei ituaiga su'ega i le lalolagi atoa e puipuia ai fa'ama'i fatu. O le maʻi fatu o le numera 1 fasioti tagata i le lalolagi - o le mea moni, o le afa o tagata Amerika e faʻamoemoe e maua ia le itiiti ifo ma le tasi le faʻalavelave fatu io latou olaga.

I le taimi atoa o le suʻesuʻega, o le vaega o le cardiology i le Dignity Health Chandler Regional Medical Center, Mercy Gilbert Medical Center ma St. Joseph's Hospital and Medical Center o le a aoina faʻataʻitaʻiga DNA mai le tusa ma le 2,000 alii ma tamaitai e leai ni tala faʻasolopito o fatu fatu. Ole DNA fa'ata'ita'iga ole a su'esu'eina ile Baylor College of Medicine's Human Genome Sequencing Center Clinical Lab e iloa ai pe o iai ni fa'ailoga fa'ailoga e iloa e mafua ai le ma'i fatu.

"E tatau ona avea lenei ma seneturi mulimuli o faʻamaʻi fatu," o le tala lea a Robert Roberts, MD, Faʻatonu Faʻafomaʻi o le Cardiovascular Genomics mo le Mamalu Soifua Maloloina i Arizona. "Ou te faʻamoemoe e ala i faʻaiʻuga o lenei suʻesuʻega o le a mafai ai ona tatou faʻaolaina le tele o ola i le lumanaʻi e ala i le faʻatinoina o suʻesuʻega faʻapitoa mo le vave puipuia o faʻamaʻi o le fatu fatu e pei o le faʻaaogaina masani ile falemaʻi."

A mae'a loa le DNA genotyping, o le a iloiloina e le 'au a le Dignity Health hospitals i Arizona fa'ailoga fa'a kenera a tagata ta'ito'atasi e iloa ai pe maualalo, feololo pe maualuga le avanoa e maua ai le ma'i fatu. O isi tulaga o le soifua maloloina ma le olaga o le a iloiloina foi pe a fuafuaina le lamatiaga o tagata auai i maʻi fatu. O ia mea e aofia ai le toto maualuga, suka, maualuga cholesterol ma pe ulaula pe o lo'o malosi le tino, ma isi.

O tagata suʻesuʻe suʻesuʻe na faʻaalia se manaʻoga e iloa a latou taunuuga o le a logoina i se tusi. O tagata ta'ito'atasi e maualuga le a'afiaga o le fatu mo ma'i fatu o le a maua le avanoa e feiloa'i ai ma tagata tomai fa'apitoa ole fatu ma fa'ata'ita'i fa'asinomaga pe a mana'omia e fa'atatau i a latou fa'ai'uga ma filifiliga talafeagai mo le puipuia.

O i latou e agavaa e auai i le suʻesuʻega o alii ma tamaitai i le va o le 40 ma le 60 tausaga. E tatau foi ona leai ni tala faʻasolopito o faʻamaʻi fatu, aua o le sini o le suʻesuʻega o le fuafuaina lea o latou faʻalavelave faʻafuaseʻi mo le atiaʻe o maʻi fatu aʻo leʻi tupu moni.

OA MEA E AVEA MAI LENEI TUSI:

Once the DNA genotyping is completed, the team at Dignity Health hospitals in Arizona will evaluate each participant’s genetic markers to determine if they have a low, medium or high chance of developing heart disease.
They must also have no known history of heart disease, as the goal of the study is to determine their genetic risk for developing heart disease before it actually develops.
“I am hopeful that through the results of this study we will be able to save even more lives in the future by implementing genetic testing for early prevention of coronary artery disease as routine clinical application.